Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Colorectal Cancer × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Uterine Cervical Neoplasms 3 Melanoma 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Lymphoma, T-Cell 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1

Interventions

Oxaliplatin 4 Cetuximab 4 regorafenib 3 Irinotecan 3 Capecitabine 3 trifluridine tipiracil drug combination 2 surufatinib 2 Fluorouracil 2 Drug Therapy 2 Bevacizumab 2 raltitrexed 1 plocabulin 1 paclitaxel poliglumex 1 nimotuzumab 1 irinotecan sucrosofate 1 endostar protein 1 durvalumab 1 defactinib 1 aflibercept 1 Panitumumab 1 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1 HMPL-013 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00853684 2009-09-18

OXCE

Shanghai Jiao Tong University School of Medicine

Phase 2 Unknown

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡